CEMIP and colorectal carcinoma: Furthermore, CEMIP is identified as a potential target of miR-140-3p, promoting the proliferation and invasion of CRC cells and reverting miR-140-3p-induced anti-proliferative effects by modulating the expression of several epithelial marker proteins.